Matches in SemOpenAlex for { <https://semopenalex.org/work/W3101726066> ?p ?o ?g. }
- W3101726066 endingPage "389" @default.
- W3101726066 startingPage "389" @default.
- W3101726066 abstract "Background: Glioblastoma multiforme is a malignant intracranial neoplasm that constitutes a therapeutic challenge because of the associated high morbidity and mortality given the lack of effective approved medication and aggressive nature of the tumor. However, there has been extensive research recently to address the reasons implicated in the resistant nature of the tumor to pharmaceutical compounds, which have resulted in several clinical trials investigating promising treatment approaches. Methods: We reviewed literature published since 2010 from PUBMED and several annual meeting abstracts through 15 September 2020. Selected articles included those relevant to topics of glioblastoma tumor biology, original basic research, clinical trials, seminal reviews, and meta-analyses. We provide a discussion based on the collected evidence regarding the challenging factors encountered during treatment, and we highlighted the relevant trials of novel therapies including immunotherapy and targeted medication. Results: Selected literature revealed four main factors implicated in the low efficacy encountered with investigational treatments which included: (1) blood-brain barrier; (2) immunosuppressive microenvironment; (3) genetic heterogeneity; (4) external factors related to previous systemic treatment that can modulate tumor microenvironment. Investigational therapies discussed in this review were classified as immunotherapy and targeted therapy. Immunotherapy included: (1) immune checkpoint inhibitors; (2) adoptive cell transfer therapy; (3) therapeutic vaccines; (4) oncolytic virus therapy. Targeted therapy included tyrosine kinase inhibitors and other receptor inhibitors. Finally, we provide our perspective on future directions in treatment of glioblastoma. Conclusion: Despite the limited success in development of effective therapeutics in glioblastoma, many treatment approaches hold potential promise including immunotherapy and novel combinational drugs. Addressing the molecular landscape and resistant immunosuppressive nature of glioblastoma are imperative in further development of effective treatments." @default.
- W3101726066 created "2020-11-23" @default.
- W3101726066 creator A5077751908 @default.
- W3101726066 creator A5080536692 @default.
- W3101726066 creator A5091279323 @default.
- W3101726066 date "2020-11-14" @default.
- W3101726066 modified "2023-10-04" @default.
- W3101726066 title "The Landscape of Novel Therapeutics and Challenges in Glioblastoma Multiforme: Contemporary State and Future Directions" @default.
- W3101726066 cites W1528827595 @default.
- W3101726066 cites W1568276869 @default.
- W3101726066 cites W1588685142 @default.
- W3101726066 cites W1791497256 @default.
- W3101726066 cites W1815157104 @default.
- W3101726066 cites W1828443506 @default.
- W3101726066 cites W1834998094 @default.
- W3101726066 cites W1893588436 @default.
- W3101726066 cites W1959444207 @default.
- W3101726066 cites W1966720603 @default.
- W3101726066 cites W1993762420 @default.
- W3101726066 cites W2000909625 @default.
- W3101726066 cites W2008259119 @default.
- W3101726066 cites W2008550171 @default.
- W3101726066 cites W2010956784 @default.
- W3101726066 cites W2011788217 @default.
- W3101726066 cites W2013020286 @default.
- W3101726066 cites W2013090484 @default.
- W3101726066 cites W2015541518 @default.
- W3101726066 cites W2022495797 @default.
- W3101726066 cites W2025183726 @default.
- W3101726066 cites W2029206557 @default.
- W3101726066 cites W2031108286 @default.
- W3101726066 cites W2035437489 @default.
- W3101726066 cites W2035833975 @default.
- W3101726066 cites W2041532314 @default.
- W3101726066 cites W2046739604 @default.
- W3101726066 cites W2048073154 @default.
- W3101726066 cites W2056679169 @default.
- W3101726066 cites W2060187394 @default.
- W3101726066 cites W2060672294 @default.
- W3101726066 cites W2061123122 @default.
- W3101726066 cites W2077200168 @default.
- W3101726066 cites W2096287682 @default.
- W3101726066 cites W2097049582 @default.
- W3101726066 cites W2102614717 @default.
- W3101726066 cites W2103959341 @default.
- W3101726066 cites W2104347254 @default.
- W3101726066 cites W2109274792 @default.
- W3101726066 cites W2109816625 @default.
- W3101726066 cites W2113729674 @default.
- W3101726066 cites W2116371946 @default.
- W3101726066 cites W2116574496 @default.
- W3101726066 cites W2117941094 @default.
- W3101726066 cites W2118471749 @default.
- W3101726066 cites W2122429434 @default.
- W3101726066 cites W2124736921 @default.
- W3101726066 cites W2130830673 @default.
- W3101726066 cites W2139004759 @default.
- W3101726066 cites W2139203226 @default.
- W3101726066 cites W2146881779 @default.
- W3101726066 cites W2148977460 @default.
- W3101726066 cites W2149387197 @default.
- W3101726066 cites W2156330848 @default.
- W3101726066 cites W2159222883 @default.
- W3101726066 cites W2160137787 @default.
- W3101726066 cites W2160382843 @default.
- W3101726066 cites W2169820958 @default.
- W3101726066 cites W2170965589 @default.
- W3101726066 cites W2184759047 @default.
- W3101726066 cites W2198093519 @default.
- W3101726066 cites W2209618509 @default.
- W3101726066 cites W2223453873 @default.
- W3101726066 cites W2303158491 @default.
- W3101726066 cites W2346904924 @default.
- W3101726066 cites W2403699476 @default.
- W3101726066 cites W2408764558 @default.
- W3101726066 cites W2410468716 @default.
- W3101726066 cites W2418524314 @default.
- W3101726066 cites W2462122693 @default.
- W3101726066 cites W2463645998 @default.
- W3101726066 cites W2467321712 @default.
- W3101726066 cites W2468037274 @default.
- W3101726066 cites W2515274402 @default.
- W3101726066 cites W2524525752 @default.
- W3101726066 cites W2559804019 @default.
- W3101726066 cites W2560189464 @default.
- W3101726066 cites W2560367415 @default.
- W3101726066 cites W2567424265 @default.
- W3101726066 cites W2567564314 @default.
- W3101726066 cites W2572174216 @default.
- W3101726066 cites W2572711501 @default.
- W3101726066 cites W2584466409 @default.
- W3101726066 cites W2591531756 @default.
- W3101726066 cites W2593059553 @default.
- W3101726066 cites W2593586113 @default.
- W3101726066 cites W2597064996 @default.
- W3101726066 cites W2600281432 @default.
- W3101726066 cites W2605626471 @default.
- W3101726066 cites W2607167117 @default.